{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:29:43Z","timestamp":1773883783976,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007867","name":"Universit\u00e9 Laval","doi-asserted-by":"publisher","award":["30641"],"award-info":[{"award-number":["30641"]}],"id":[{"id":"10.13039\/100007867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020951","name":"Fonds de recherche du Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["485777"],"award-info":[{"award-number":["485777"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004888","name":"Centre Hospitalier Universitaire de Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010785","name":"Canada First Research Excellence Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.nano.2025.102887","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:17:08Z","timestamp":1764922628000},"page":"102887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from Imidazoquinolines"],"prefix":"10.1016","volume":"71","author":[{"given":"Maril\u00e8ne","family":"Bolduc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Saint-Louis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Carignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Garneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Breton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Rancourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko S.","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9gan","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henintsoa","family":"Rabezanahary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Baz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Dubuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Flamand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Leclerc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2025.102887_bb0005","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/v3060920","article-title":"Pattern recognition receptors and the innate immune response to viral infection","volume":"3","author":"Thompson","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.nano.2025.102887_bb0010","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fimmu.2014.00386","article-title":"TLR-dependent human mucosal epithelial cell responses to microbial pathogens","volume":"5","author":"McClure","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.756315","article-title":"Toll-like receptors as a therapeutic target in the era of immunotherapies","volume":"9","author":"Farooq","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.nano.2025.102887_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.622614","article-title":"TLR agonists as mediators of trained immunity: mechanistic insight and immunotherapeutic potential to combat infection","volume":"11","author":"Owen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0025","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0274-2021","article-title":"Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell","volume":"31","author":"Girkin","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.nano.2025.102887_bb0030","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.nano.2013.02.009","article-title":"Induction of innate immunity in lungs with virus-like nanoparticles leads to protection against influenza and Streptococcus pneumoniae challenge","volume":"9","author":"Mathieu","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2025.102887_bb0035","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3389\/fimmu.2020.01075","article-title":"Adjuvant effect of toll-like receptor 9 activation on cancer immunotherapy using checkpoint blockade","volume":"11","author":"Chuang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0040","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1080\/21645515.2018.1445947","article-title":"Genital warts treatment: beyond imiquimod","volume":"14","author":"Yuan","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.nano.2025.102887_bb0045","first-page":"CD003412","article-title":"Interventions for basal cell carcinoma of the skin","volume":"11","author":"Thomson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nano.2025.102887_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14165","article-title":"The role of topical imiquimod in melanoma cutaneous metastases: a critical review of the literature","volume":"33","author":"Scarf\u00ec","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.nano.2025.102887_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/ecp.11.5","article-title":"The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system","volume":"2","author":"Engel","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.nano.2025.102887_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18671-1","article-title":"A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB\/c mice","volume":"12","author":"Jamshaid","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2025.102887_bb0065","doi-asserted-by":"crossref","first-page":"16570","DOI":"10.1038\/s41598-017-16707-5","article-title":"The systemic response to topical Aldara treatment is mediated through direct TLR7 stimulation as imiquimod enters the circulation","volume":"7","author":"Nerurkar","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2025.102887_bb0070","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.immuni.2016.09.011","article-title":"Structural analysis reveals that toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA","volume":"45","author":"Zhang","year":"2016","journal-title":"Immunity"},{"issue":"109","key":"10.1016\/j.nano.2025.102887_bb0075","first-page":"115","article-title":"Toll-like receptor 8 senses degradation products of single-stranded RNA","volume":"22","author":"Tanji","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.nano.2025.102887_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.05.013","article-title":"Evolution of Toll-like receptor 7\/8 agonist therapeutics and their delivery approaches: from antiviral formulations to vaccine adjuvants","volume":"175","author":"Bhagchandani","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102887_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/08830185.2016.1261318","article-title":"Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells","volume":"36","author":"Tartey","year":"2017","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood-2012-05-432393","article-title":"Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma","volume":"121","author":"Dovedi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.nano.2025.102887_bb0095","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1158\/1078-0432.CCR-07-1443","article-title":"First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer","volume":"13","author":"Dudek","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nano.2025.102887_bb0100","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1016\/j.vaccine.2011.05.061","article-title":"Vaccine adjuvant activity of 3m-052: an imidazoquinoline designed for local activity without systemic cytokine induction","volume":"29","author":"Smirnov","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2025.102887_bb0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/vaccines8030393","article-title":"A randomized controlled study to evaluate the safety and reactogenicity of a novel rVLP-based plant virus nanoparticle adjuvant combined with seasonal trivalent influenza vaccine following single immunization in healthy adults 18-50 years of age","volume":"8","author":"Langley","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.nano.2025.102887_bb0110","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4049\/jimmunol.1302030","article-title":"Nanoparticle adjuvant sensing by TLR7 enhances CD8+ T cell-mediated protection from Listeria monocytogenes infection","volume":"192","author":"Lebel","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1477-3155-12-19","article-title":"PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine","volume":"12","author":"Rioux","year":"2014","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102887_bb0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12951-017-0289-y","article-title":"A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling","volume":"15","author":"Th\u00e9rien","year":"2017","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102887_bb0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jmb.2012.05.032","article-title":"Crystal structure of the coat protein of the flexible filamentous papaya mosaic virus","volume":"422","author":"Yang","year":"2012","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nano.2025.102887_bb0130","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.nano.2017.10.015","article-title":"Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7\/8 agonist","volume":"7","author":"Carignan","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2025.102887_bb0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/vaccines9010033","article-title":"Modulation of antigen display on PapMV nanoparticles influences its immunogenicity","volume":"9","author":"Lalibert\u00e9-Gagn\u00e9","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.nano.2025.102887_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12177","article-title":"Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution","volume":"7","author":"Luo","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2025.102887_bb0145","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.nano.2018.08.010","article-title":"The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses","author":"Bolduc","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2025.102887_bb0150","article-title":"A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection","volume":"44","author":"Olivera-Ugarte","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2025.102887_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021522","article-title":"Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticles","volume":"6","author":"Savard","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2025.102887_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000516780","article-title":"Metabolic regulation of macrophage activation","volume":"14","author":"Kolliniati","year":"2022","journal-title":"J Innate Immun"},{"key":"10.1016\/j.nano.2025.102887_bb0165","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"Arango Duque","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0170","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cellimm.2011.08.008","article-title":"The TLR7\/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation","volume":"271","author":"Hackstein","year":"2011","journal-title":"Cell Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0175","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q","article-title":"Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells","volume":"31","author":"Jarrossay","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0180","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72498","article-title":"Empirical single-cell tracking and cell-fate simulation reveal dual roles of p53 in tumor suppression","volume":"11","author":"Rancourt","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.nano.2025.102887_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.743890","article-title":"Imiquimod boosts interferon response, and decreases ACE2 and pro-inflammatory response of human bronchial epithelium in asthma","volume":"12","author":"Nieto-Fontarigo","year":"2021","journal-title":"Front Immunol"},{"issue":"14","key":"10.1016\/j.nano.2025.102887_bb0190","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.3390\/ijms25147661","article-title":"Immune stimulation with imiquimod to best face SARS-CoV-2 infection and prevent long COVID","volume":"25","author":"Pacheco-Garc\u00eda","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102887_bb0195","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fimmu.2018.00270","article-title":"Metabolic modulation in macrophage effector function","volume":"9","author":"Diskin","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0200","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3389\/fimmu.2020.01097","article-title":"Physical constraints and forces involved in phagocytosis","volume":"11","author":"Jaumouill\u00e9","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0205","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/imr.12118","article-title":"Generation of membrane structures during phagocytosis and chemotaxis of macrophages: role and regulation of the actin cytoskeleton","volume":"256","author":"Rougerie","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.nano.2025.102887_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105563","article-title":"Macrophage 3D migration: a potential therapeutic target for inflammation and deleterious progression in diseases","volume":"167","author":"Gao","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.nano.2025.102887_bb0215","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.immuni.2016.08.010","article-title":"K+ efflux-independent NLRP3 Inflammasome activation by small molecules targeting mitochondria","volume":"45","author":"Gro\u00df","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.nano.2025.102887_bb0220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40364-022-00436-7","article-title":"Targeting toll-like receptor 7\/8 for immunotherapy: recent advances and prospectives","volume":"10","author":"Sun","year":"2022","journal-title":"Biomark Res"},{"key":"10.1016\/j.nano.2025.102887_bb0225","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1074\/jbc.M116.774471","article-title":"Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements","volume":"292","author":"Mookerjee","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2025.102887_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101674","article-title":"Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement","volume":"37","author":"Nolfi-Donegan","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.nano.2025.102887_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734229","article-title":"Reactive oxygen species in macrophages: sources and targets","volume":"12","author":"Canton","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.708186","article-title":"Macrophages: the good, the bad, and the gluttony","volume":"12","author":"Ross","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12950-023-00360-z","article-title":"Advances in the study of macrophage polarization in inflammatory immune skin diseases","volume":"20","author":"Xia","year":"2023","journal-title":"J Inflamm"},{"key":"10.1016\/j.nano.2025.102887_bb0250","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20210764","article-title":"Hypoxia-induced PTTG3P contributes to colorectal cancer glycolysis and M2 phenotype of macrophage","volume":"41","author":"Wang","year":"2021","journal-title":"Biosci Rep"},{"key":"10.1016\/j.nano.2025.102887_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202100127","article-title":"Nanoparticle internalization promotes the survival of primary macrophages","volume":"2","author":"Jarai","year":"2022","journal-title":"Adv Nanobiomed Res"},{"key":"10.1016\/j.nano.2025.102887_bb0260","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.4049\/jimmunol.1303058","article-title":"RNA and imidazoquinolines are sensed by distinct TLR7\/8 ectodomain sites resulting in functionally disparate signaling events","volume":"192","author":"Colak","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2025.102887_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911740","article-title":"Cytokine storm-definition, causes, and implications","volume":"23","author":"Jarczak","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102887_bb0270","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00262-020-02822-2","article-title":"Are all cytokine storms the same?","volume":"70","author":"Panoskaltsis","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.nano.2025.102887_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104817","article-title":"Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs","volume":"179","author":"Salinas","year":"2020","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.nano.2025.102887_bb0280","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.antiviral.2011.03.181","article-title":"Evaluation of imiquimod for topical treatment of vaccinia virus cutaneous infections in immunosuppressed hairless mice","volume":"90","author":"Tarbet","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.nano.2025.102887_bb0285","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/00015555-832143","article-title":"Imiquimod: mode of action an therapeutic potential","volume":"214","author":"Chosidow","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.nano.2025.102887_bb0290","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85647","article-title":"TLR7 activation at epithelial barriers promotes emergency myelopoiesis and lung antiviral immunity","volume":"12","author":"Jackson","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.nano.2025.102887_bb0295","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-38864-5","article-title":"Intranasal and epicutaneous administration of Toll-like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in mice","volume":"9","author":"To","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2025.102887_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.590","article-title":"Impact of latency-reversing agents on human macrophage physiology","volume":"11","author":"Hany","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.nano.2025.102887_bb0305","article-title":"Single-cell lineage tracking analysis reveals that an established cell line comprises putative cancer stem cells and their heterogeneous progeny","volume":"6","author":"Sato","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2025.102887_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107697","article-title":"Cell fate simulation reveals cancer cell features in the tumor microenvironment","volume":"300","author":"Sato","year":"2024","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2025.102887_bb0315","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-12-416618-9.00007-8","article-title":"Extracellular flux analysis to monitor glycolytic rates and mitochondrial oxygen consumption","volume":"542","author":"Pelletier","year":"2014","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.nano.2025.102887_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110336","article-title":"Bisphenol A, bisphenol S and their glucuronidated metabolites modulate glycolysis and functional responses of human neutrophils","volume":"196","author":"Peillex","year":"2021","journal-title":"Environ Res"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:45:48Z","timestamp":1773863148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963425000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":64,"alternative-id":["S1549963425000887"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102887","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from Imidazoquinolines","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102887"}}